INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. – AGL

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether agilon and certain of its officers and/or directors have engaged […]

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. – INSP

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Inspire and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming Deadlines – LFMD

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company”)(NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. – CFLT

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Confluent and certain of its officers and/or directors have engaged in

Securities Lawsuit Alert: Fly-E Group, Inc. (FLYE) Investors – Contact Levi & Korsinsky Before November 7, 2025

NEW YORK, NY / ACCESS Newswire / September 10, 2025 / If you suffered a loss on your Fly-E Group, Inc. (NASDAQ:FLYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fly-e-group-inc-lawsuit-submission-form?prid=166478&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lantheus Holdings, Inc. – LNTH

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lantheus and certain of its officers and/or directors have engaged

ACT Capital Advisors Represents Derotic Emergency Equipment in its Sale to Amerit Fleet Solutions

ACT Capital Advisors is pleased to announce the successful acquisition of its client, Derotic Emergency Equipment (“Derotic”), by strategic buyer Amerit Fleet Solutions (“Amerit”). The transaction officially closed in August 2025. Derotic, headquartered in California, is a premier upfitter of fire, police, emergency, utility, and other government vehicles with a national reach. ACT Capital Advisors’

MySmile Launches Fluoride-Free Toothpaste for Enamel Repair

Los Angeles-based MySmile introduces its Nano-Hydroxyapatite Toothpaste, designed to remineralize enamel, reduce sensitivity, and deliver freshness without fluoride, now available nationwide. MySmile, a Los Angeles-based leader in innovative oral care solutions, is proud to announce the launch of its Nano-Hydroxyapatite Toothpaste, a cutting-edge formula designed to remineralize enamel, reduce sensitivity, and deliver long-lasting freshness –

TVM Capital Healthcare Announces First Closing of its USD 150 Million Southeast Asia Fund

TVMCapital Healthcare, a global private equity investor and operator specialized in healthcare growth capital across emerging markets, today announced the first closing of its USD 150 million TVMHealthcare Southeast Asia Fund (“SEA Fund”). https://mma.prnewswire.com/media/1446186/4906310/TVM_Capital_Healthcare_Logo.jpg The SEA Fund is the third generation of TVM Capital Healthcare funds and builds on the firm’s nearly 40 years of

Scroll to Top